Skip to main content
NCBI home page
Journal of Virology logoLink to Journal of Virology
. 1994 Jul;68(7):4557–4564. doi: 10.1128/jvi.68.7.4557-4564.1994

Unprocessed foot-and-mouth disease virus capsid precursor displays discontinuous epitopes involved in viral neutralization.

J C Sáiz 1, J Cairó 1, M Medina 1, D Zuidema 1, C Abrams 1, G J Belsham 1, E Domingo 1, J M Vlak 1
PMCID: PMC236382  PMID: 7515974

Abstract

A foot-and-mouth disease virus (FMDV) cDNA cassette containing sequences encoding the capsid precursor P1, peptide 2A and a truncated 2B (abbreviated P1-2A) of type C FMDV, has been modified to generate the authentic amino terminus and the myristoylation signal. This construct has been used to produce a recombinant baculovirus (AcMM53) which, upon infection of Spodoptera frugiperda insect cells, expressed a recombinant P1-2A precursor with a high yield. This polyprotein reacted with neutralizing monoclonal antibodies (MAbs) that bind to continuous epitopes of the major antigenic site A (also termed site 1) of capsid protein VP1. Unexpectedly, it also reacted with neutralizing MAbs which define complex, discontinuous epitopes previously identified on FMDV particles. The reactivity of MAbs with P1-2A was quantitatively similar to their reactivity with intact virus and, in both cases, the reactivity with MAbs that recognized discontinuous epitopes was lost upon heat denaturation of the antigen. The finding that a capsid precursor may fold in such a way as to maintain discontinuous epitopes involved in virus neutralization present on the virion surface opens the possibility of using unprocessed capsid precursors as novel antiviral immunogens.

Full text

PDF
4557

Images in this article

4560Image
on p.4560

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Acharya R., Fry E., Stuart D., Fox G., Rowlands D., Brown F. The three-dimensional structure of foot-and-mouth disease virus at 2.9 A resolution. Nature. 1989 Feb 23;337(6209):709–716. doi: 10.1038/337709a0. [DOI] [PubMed] [Google Scholar]
  2. Bachrach H. L., Moore D. M., McKercher P. D., Polatnick J. Immune and antibody responses to an isolated capsid protein of foot-and-mouth disease virus. J Immunol. 1975 Dec;115(6):1636–1641. [PubMed] [Google Scholar]
  3. Barnett P. V., Ouldridge E. J., Rowlands D. J., Brown F., Parry N. R. Neutralizing epitopes of type O foot-and-mouth disease virus. I. Identification and characterization of three functionally independent, conformational sites. J Gen Virol. 1989 Jun;70(Pt 6):1483–1491. doi: 10.1099/0022-1317-70-6-1483. [DOI] [PubMed] [Google Scholar]
  4. Baxt B., Vakharia V., Moore D. M., Franke A. J., Morgan D. O. Analysis of neutralizing antigenic sites on the surface of type A12 foot-and-mouth disease virus. J Virol. 1989 May;63(5):2143–2151. doi: 10.1128/jvi.63.5.2143-2151.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Beck E., Strohmaier K. Subtyping of European foot-and-mouth disease virus strains by nucleotide sequence determination. J Virol. 1987 May;61(5):1621–1629. doi: 10.1128/jvi.61.5.1621-1629.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Belsham G. J., Abrams C. C., King A. M., Roosien J., Vlak J. M. Myristoylation of foot-and-mouth disease virus capsid protein precursors is independent of other viral proteins and occurs in both mammalian and insect cells. J Gen Virol. 1991 Mar;72(Pt 3):747–751. doi: 10.1099/0022-1317-72-3-747. [DOI] [PubMed] [Google Scholar]
  7. Belsham G. J., Brangwyn J. K. A region of the 5' noncoding region of foot-and-mouth disease virus RNA directs efficient internal initiation of protein synthesis within cells: involvement with the role of L protease in translational control. J Virol. 1990 Nov;64(11):5389–5395. doi: 10.1128/jvi.64.11.5389-5395.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Belsham G. J., Brangwyn J. K., Ryan M. D., Abrams C. C., King A. M. Intracellular expression and processing of foot-and-mouth disease virus capsid precursors using vaccinia virus vectors: influence of the L protease. Virology. 1990 Jun;176(2):524–530. doi: 10.1016/0042-6822(90)90022-j. [DOI] [PubMed] [Google Scholar]
  9. Belsham G. J. Distinctive features of foot-and-mouth disease virus, a member of the picornavirus family; aspects of virus protein synthesis, protein processing and structure. Prog Biophys Mol Biol. 1993;60(3):241–260. doi: 10.1016/0079-6107(93)90016-D. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Bittle J. L., Houghten R. A., Alexander H., Shinnick T. M., Sutcliffe J. G., Lerner R. A., Rowlands D. J., Brown F. Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature. 1982 Jul 1;298(5869):30–33. doi: 10.1038/298030a0. [DOI] [PubMed] [Google Scholar]
  11. Braakman I., Hoover-Litty H., Wagner K. R., Helenius A. Folding of influenza hemagglutinin in the endoplasmic reticulum. J Cell Biol. 1991 Aug;114(3):401–411. doi: 10.1083/jcb.114.3.401. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Broekhuijsen M. P., van Rijn J. M., Blom A. J., Pouwels P. H., Enger-Valk B. E., Brown F., Francis M. J. Fusion proteins with multiple copies of the major antigenic determinant of foot-and-mouth disease virus protect both the natural host and laboratory animals. J Gen Virol. 1987 Dec;68(Pt 12):3137–3143. doi: 10.1099/0022-1317-68-12-3137. [DOI] [PubMed] [Google Scholar]
  13. Bräutigam S., Snezhkov E., Bishop D. H. Formation of poliovirus-like particles by recombinant baculoviruses expressing the individual VP0, VP3, and VP1 proteins by comparison to particles derived from the expressed poliovirus polyprotein. Virology. 1993 Feb;192(2):512–524. doi: 10.1006/viro.1993.1067. [DOI] [PubMed] [Google Scholar]
  14. Carrillo C., Dopazo J., Moya A., Gonzalez M., Martínez M. A., Saiz J. C., Sobrino F. Comparison of vaccine strains and the virus causing the 1986 foot-and-mouth disease outbreak in Spain: epizootiological analysis. Virus Res. 1990 Jan;15(1):45–55. doi: 10.1016/0168-1702(90)90012-z. [DOI] [PubMed] [Google Scholar]
  15. Clarke B. E., Newton S. E., Carroll A. R., Francis M. J., Appleyard G., Syred A. D., Highfield P. E., Rowlands D. J., Brown F. Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein. 1987 Nov 26-Dec 2Nature. 330(6146):381–384. doi: 10.1038/330381a0. [DOI] [PubMed] [Google Scholar]
  16. Clarke B. E., Sangar D. V. Processing and assembly of foot-and-mouth disease virus proteins using subgenomic RNA. J Gen Virol. 1988 Sep;69(Pt 9):2313–2325. doi: 10.1099/0022-1317-69-9-2313. [DOI] [PubMed] [Google Scholar]
  17. Collen T., Dimarchi R., Doel T. R. A T cell epitope in VP1 of foot-and-mouth disease virus is immunodominant for vaccinated cattle. J Immunol. 1991 Jan 15;146(2):749–755. [PubMed] [Google Scholar]
  18. Collen T., Doel T. R. Heterotypic recognition of foot-and-mouth disease virus by cattle lymphocytes. J Gen Virol. 1990 Feb;71(Pt 2):309–315. doi: 10.1099/0022-1317-71-2-309. [DOI] [PubMed] [Google Scholar]
  19. Devaney M. A., Vakharia V. N., Lloyd R. E., Ehrenfeld E., Grubman M. J. Leader protein of foot-and-mouth disease virus is required for cleavage of the p220 component of the cap-binding protein complex. J Virol. 1988 Nov;62(11):4407–4409. doi: 10.1128/jvi.62.11.4407-4409.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. DiMarchi R., Brooke G., Gale C., Cracknell V., Doel T., Mowat N. Protection of cattle against foot-and-mouth disease by a synthetic peptide. Science. 1986 May 2;232(4750):639–641. doi: 10.1126/science.3008333. [DOI] [PubMed] [Google Scholar]
  21. Doms R. W., Lamb R. A., Rose J. K., Helenius A. Folding and assembly of viral membrane proteins. Virology. 1993 Apr;193(2):545–562. doi: 10.1006/viro.1993.1164. [DOI] [PubMed] [Google Scholar]
  22. Feigelstock D., Mateu M. G., Piccone M. E., De Simone F., Brocchi E., Domingo E., Palma E. L. Extensive antigenic diversification of foot-and-mouth disease virus by amino acid substitutions outside the major antigenic site. J Gen Virol. 1992 Dec;73(Pt 12):3307–3311. doi: 10.1099/0022-1317-73-12-3307. [DOI] [PubMed] [Google Scholar]
  23. Fuerst T. R., Niles E. G., Studier F. W., Moss B. Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc Natl Acad Sci U S A. 1986 Nov;83(21):8122–8126. doi: 10.1073/pnas.83.21.8122. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Groebe D. R., Chung A. E., Ho C. Cationic lipid-mediated co-transfection of insect cells. Nucleic Acids Res. 1990 Jul 11;18(13):4033–4033. doi: 10.1093/nar/18.13.4033. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Grubman M. J., Lewis S. A., Morgan D. O. Protection of swine against foot-and-mouth disease with viral capsid proteins expressed in heterologous systems. Vaccine. 1993;11(8):825–829. doi: 10.1016/0264-410x(93)90357-4. [DOI] [PubMed] [Google Scholar]
  26. Grubman M. J., Morgan D. O. Antigenic comparison of foot-and-mouth disease virus serotypes with monoclonal antibodies. Virus Res. 1986 Oct;6(1):33–43. doi: 10.1016/0168-1702(86)90055-9. [DOI] [PubMed] [Google Scholar]
  27. Grubman M. J., Morgan D. O., Kendall J., Baxt B. Capsid intermediates assembled in a foot-and-mouth disease virus genome RNA-programmed cell-free translation system and in infected cells. J Virol. 1985 Oct;56(1):120–126. doi: 10.1128/jvi.56.1.120-126.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Hink W. F. Established insect cell line from the cabbage looper, Trichoplusia ni. Nature. 1970 May 2;226(5244):466–467. doi: 10.1038/226466b0. [DOI] [PubMed] [Google Scholar]
  29. Kitson J. D., McCahon D., Belsham G. J. Sequence analysis of monoclonal antibody resistant mutants of type O foot and mouth disease virus: evidence for the involvement of the three surface exposed capsid proteins in four antigenic sites. Virology. 1990 Nov;179(1):26–34. doi: 10.1016/0042-6822(90)90269-w. [DOI] [PubMed] [Google Scholar]
  30. Kitts P. A., Ayres M. D., Possee R. D. Linearization of baculovirus DNA enhances the recovery of recombinant virus expression vectors. Nucleic Acids Res. 1990 Oct 11;18(19):5667–5672. doi: 10.1093/nar/18.19.5667. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Kleid D. G., Yansura D., Small B., Dowbenko D., Moore D. M., Grubman M. J., McKercher P. D., Morgan D. O., Robertson B. H., Bachrach H. L. Cloned viral protein vaccine for foot-and-mouth disease: responses in cattle and swine. Science. 1981 Dec 4;214(4525):1125–1129. doi: 10.1126/science.6272395. [DOI] [PubMed] [Google Scholar]
  32. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  33. Laporte J., Grosclaude J., Wantyghem J., Bernard S., Rouzé P. Neutralisation en culture cellulaire du pouvoir infectieuz du virus de la fièvre aphteuse par des sérums provenant de porcs immunisés à l'aide d'une protéine virale purifiée. C R Acad Sci Hebd Seances Acad Sci D. 1973 Jun 18;276(25):3399–3401. [PubMed] [Google Scholar]
  34. Lea S., Hernández J., Blakemore W., Brocchi E., Curry S., Domingo E., Fry E., Abu-Ghazaleh R., King A., Newman J. The structure and antigenicity of a type C foot-and-mouth disease virus. Structure. 1994 Feb 15;2(2):123–139. doi: 10.1016/s0969-2126(00)00014-9. [DOI] [PubMed] [Google Scholar]
  35. Lewis S. A., Morgan D. O., Grubman M. J. Expression, processing, and assembly of foot-and-mouth disease virus capsid structures in heterologous systems: induction of a neutralizing antibody response in guinea pigs. J Virol. 1991 Dec;65(12):6572–6580. doi: 10.1128/jvi.65.12.6572-6580.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Mateu M. G., Da Silva J. L., Rocha E., De Brum D. L., Alonso A., Enjuanes L., Domingo E., Barahona H. Extensive antigenic heterogeneity of foot-and-mouth disease virus of serotype C. Virology. 1988 Nov;167(1):113–124. doi: 10.1016/0042-6822(88)90060-8. [DOI] [PubMed] [Google Scholar]
  37. Mateu M. G., Hernández J., Martínez M. A., Feigelstock D., Lea S., Pérez J. J., Giralt E., Stuart D., Palma E. L., Domingo E. Antigenic heterogeneity of a foot-and-mouth disease virus serotype in the field is mediated by very limited sequence variation at several antigenic sites. J Virol. 1994 Mar;68(3):1407–1417. doi: 10.1128/jvi.68.3.1407-1417.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Mateu M. G., Martínez M. A., Capucci L., Andreu D., Giralt E., Sobrino F., Brocchi E., Domingo E. A single amino acid substitution affects multiple overlapping epitopes in the major antigenic site of foot-and-mouth disease virus of serotype C. J Gen Virol. 1990 Mar;71(Pt 3):629–637. doi: 10.1099/0022-1317-71-3-629. [DOI] [PubMed] [Google Scholar]
  39. Mateu M. G., Martínez M. A., Rocha E., Andreu D., Parejo J., Giralt E., Sobrino F., Domingo E. Implications of a quasispecies genome structure: effect of frequent, naturally occurring amino acid substitutions on the antigenicity of foot-and-mouth disease virus. Proc Natl Acad Sci U S A. 1989 Aug;86(15):5883–5887. doi: 10.1073/pnas.86.15.5883. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Mateu M. G., Rocha E., Vicente O., Vayreda F., Navalpotro C., Andreu D., Pedroso E., Giralt E., Enjuanes L., Domingo E. Reactivity with monoclonal antibodies of viruses from an episode of foot-and-mouth disease. Virus Res. 1987 Sep;8(3):261–274. doi: 10.1016/0168-1702(87)90020-7. [DOI] [PubMed] [Google Scholar]
  41. Medina M., Domingo E., Brangwyn J. K., Belsham G. J. The two species of the foot-and-mouth disease virus leader protein, expressed individually, exhibit the same activities. Virology. 1993 May;194(1):355–359. doi: 10.1006/viro.1993.1267. [DOI] [PubMed] [Google Scholar]
  42. Moscufo N., Simons J., Chow M. Myristoylation is important at multiple stages in poliovirus assembly. J Virol. 1991 May;65(5):2372–2380. doi: 10.1128/jvi.65.5.2372-2380.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Pfaff E., Mussgay M., Böhm H. O., Schulz G. E., Schaller H. Antibodies against a preselected peptide recognize and neutralize foot and mouth disease virus. EMBO J. 1982;1(7):869–874. doi: 10.1002/j.1460-2075.1982.tb01262.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Roosien J., Belsham G. J., Ryan M. D., King A. M., Vlak J. M. Synthesis of foot-and-mouth disease virus capsid proteins in insect cells using baculovirus expression vectors. J Gen Virol. 1990 Aug;71(Pt 8):1703–1711. doi: 10.1099/0022-1317-71-8-1703. [DOI] [PubMed] [Google Scholar]
  45. Rweyemamu M. M., Terry G., Pay T. W. Stability and immunogenicity of empty particles of foot-and-mouth disease virus. Arch Virol. 1979;59(1-2):69–79. doi: 10.1007/BF01317896. [DOI] [PubMed] [Google Scholar]
  46. Ryan M. D., Belsham G. J., King A. M. Specificity of enzyme-substrate interactions in foot-and-mouth disease virus polyprotein processing. Virology. 1989 Nov;173(1):35–45. doi: 10.1016/0042-6822(89)90219-5. [DOI] [PubMed] [Google Scholar]
  47. Saiz J. C., Gonzalez M. J., Borca M. V., Sobrino F., Moore D. M. Identification of neutralizing antigenic sites on VP1 and VP2 of type A5 foot-and-mouth disease virus, defined by neutralization-resistant variants. J Virol. 1991 May;65(5):2518–2524. doi: 10.1128/jvi.65.5.2518-2524.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Saiz J. C., Gonzalez M. J., Morgan D. O., Card J. L., Sobrino F., Moore D. M. Antigenic comparison of different foot-and-mouth disease virus types using monoclonal antibodies defining multiple neutralizing epitopes on FMDV A5 subtypes. Virus Res. 1989 May;13(1):45–60. doi: 10.1016/0168-1702(89)90086-5. [DOI] [PubMed] [Google Scholar]
  49. Sobrino F., Dávila M., Ortín J., Domingo E. Multiple genetic variants arise in the course of replication of foot-and-mouth disease virus in cell culture. Virology. 1983 Jul 30;128(2):310–318. doi: 10.1016/0042-6822(83)90258-1. [DOI] [PubMed] [Google Scholar]
  50. Sobrino F., Palma E. L., Beck E., Dávila M., de la Torre J. C., Negro P., Villanueva N., Ortín J., Domingo E. Fixation of mutations in the viral genome during an outbreak of foot-and-mouth disease: heterogeneity and rate variations. Gene. 1986;50(1-3):149–159. doi: 10.1016/0378-1119(86)90320-3. [DOI] [PubMed] [Google Scholar]
  51. Stave J. W., Card J. L., Morgan D. O. Analysis of foot-and-mouth disease virus type O1 Brugge neutralization epitopes using monoclonal antibodies. J Gen Virol. 1986 Oct;67(Pt 10):2083–2092. doi: 10.1099/0022-1317-67-10-2083. [DOI] [PubMed] [Google Scholar]
  52. Strebel K., Beck E. A second protease of foot-and-mouth disease virus. J Virol. 1986 Jun;58(3):893–899. doi: 10.1128/jvi.58.3.893-899.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Strohmaier K., Franze R., Adam K. H. Location and characterization of the antigenic portion of the FMDV immunizing protein. J Gen Virol. 1982 Apr;59(Pt 2):295–306. doi: 10.1099/0022-1317-59-2-295. [DOI] [PubMed] [Google Scholar]
  54. Sáiz J. C., Rodríguez A., González M., Alonso F., Sobrino F. Heterotypic lymphoproliferative response in pigs vaccinated with foot-and-mouth disease virus. Involvement of isolated capsid proteins. J Gen Virol. 1992 Oct;73(Pt 10):2601–2607. doi: 10.1099/0022-1317-73-10-2601. [DOI] [PubMed] [Google Scholar]
  55. Vaughn J. L., Goodwin R. H., Tompkins G. J., McCawley P. The establishment of two cell lines from the insect Spodoptera frugiperda (Lepidoptera; Noctuidae). In Vitro. 1977 Apr;13(4):213–217. doi: 10.1007/BF02615077. [DOI] [PubMed] [Google Scholar]
  56. Villanueva N., Dávila M., Ortín J., Domingo E. Molecular cloning of cDNA from foot-and-mouth disease virus C1-Santa Pau (C-S8). Sequence of protein-VP1-coding segment. Gene. 1983 Aug;23(2):185–194. doi: 10.1016/0378-1119(83)90050-1. [DOI] [PubMed] [Google Scholar]
  57. Vlak J. M., Keus R. J. Baculovirus expression vector system for production of viral vaccines. Adv Biotechnol Processes. 1990;14:91–128. [PubMed] [Google Scholar]
  58. Ypma-Wong M. F., Semler B. L. Processing determinants required for in vitro cleavage of the poliovirus P1 precursor to capsid proteins. J Virol. 1987 Oct;61(10):3181–3189. doi: 10.1128/jvi.61.10.3181-3189.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Zuidema D., Schouten A., Usmany M., Maule A. J., Belsham G. J., Roosien J., Klinge-Roode E. C., van Lent J. W., Vlak J. M. Expression of cauliflower mosaic virus gene I in insect cells using a novel polyhedrin-based baculovirus expression vector. J Gen Virol. 1990 Oct;71(Pt 10):2201–2209. doi: 10.1099/0022-1317-71-10-2201. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES